Literature DB >> 16083259

Perspective: a program to improve protein biomarker discovery for cancer.

Ruedi Aebersold1, Leigh Anderson, Richard Caprioli, Brian Druker, Leland Hartwell, Richard Smith.   

Abstract

Biomarkers for cancer risk, early detection, prognosis, and therapeutic response promise to revolutionize cancer management. Protein biomarkers offer tremendous potential in this regard due to their great diversity and intimate involvement in physiology. An effective program to discover protein biomarkers using existing technology will require team science, an integrated informatics platform, identification and quantitation of candidate biomarkers in disease tissue, mouse models of disease, standardized reagents for analyzing candidate biomarkers in bodily fluids, and implementation of automation. Technology improvements for better fractionation of the proteome, selection of specific biomarkers from complex mixtures, and multiplexed assay of biomarkers would greatly enhance progress.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16083259     DOI： 10.1021/pr050027n

Source DB:  PubMed          Journal:  J Proteome Res        ISSN： 1535-3893            Impact factor:   4.466


  44 in total

1.  Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure.

Authors:  Jiang Zhang; Moltu J Guy; Holly S Norman; Yi-Chen Chen; Qingge Xu; Xintong Dong; Huseyin Guner; Sijian Wang; Takushi Kohmoto; Ken H Young; Richard L Moss; Ying Ge
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

2.  Calorimetry outside the box: a new window into the plasma proteome.

Authors:  Nichola C Garbett; James J Miller; Alfred B Jenson; Jonathan B Chaires
Journal:  Biophys J       Date:  2007-10-19       Impact factor: 4.033

3.  Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation.

Authors:  Alessandra Luchini; David H Geho; Barney Bishop; Duy Tran; Cassandra Xia; Robert L Dufour; Clinton D Jones; Virginia Espina; Alexis Patanarut; Weidong Zhou; Mark M Ross; Alessandra Tessitore; Emanuel F Petricoin; Lance A Liotta
Journal:  Nano Lett       Date:  2007-12-13       Impact factor: 11.189

4.  An insight into high-resolution mass-spectrometry data.

Authors:  J E Eckel-Passow; A L Oberg; T M Therneau; H R Bergen
Journal:  Biostatistics       Date:  2009-03-26       Impact factor: 5.899

Review 5.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

6.  Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker.

Authors:  Un-Beom Kang; Younghee Ahn; Jong Won Lee; Yong-Hak Kim; Joon Kim; Myeong-Hee Yu; Dong-Young Noh; Cheolju Lee
Journal:  BMC Cancer       Date:  2010-03-26       Impact factor: 4.430

7.  Identification of ENO1 as a potential sputum biomarker for early-stage lung cancer by shotgun proteomics.

Authors:  Lei Yu; Jun Shen; Kaiissar Mannoor; Maria Guarnera; Feng Jiang
Journal:  Clin Lung Cancer       Date:  2014-06-03       Impact factor: 4.785

8.  An LC-IMS-MS platform providing increased dynamic range for high-throughput proteomic studies.

Authors:  Erin Shammel Baker; Eric A Livesay; Daniel J Orton; Ronald J Moore; William F Danielson; David C Prior; Yehia M Ibrahim; Brian L LaMarche; Anoop M Mayampurath; Athena A Schepmoes; Derek F Hopkins; Keqi Tang; Richard D Smith; Mikhail E Belov
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

9.  Single-wall carbon nanotube forest arrays for immunoelectrochemical measurement of four protein biomarkers for prostate cancer.

Authors:  Bhaskara V Chikkaveeraiah; Ashwin Bhirde; Ruchika Malhotra; Vyomesh Patel; J Silvio Gutkind; James F Rusling
Journal:  Anal Chem       Date:  2009-11-01       Impact factor: 6.986

Review 10.  Glycoproteomics in neurodegenerative diseases.

Authors:  Hyejin Hwang; Jianpeng Zhang; Kathryn A Chung; James B Leverenz; Cyrus P Zabetian; Elaine R Peskind; Joseph Jankovic; Zhen Su; Aneeka M Hancock; Catherine Pan; Thomas J Montine; Sheng Pan; John Nutt; Roger Albin; Marla Gearing; Richard P Beyer; Min Shi; Jing Zhang
Journal:  Mass Spectrom Rev       Date:  2010 Jan-Feb       Impact factor: 10.946
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.